News Earnings DCMSIL Schedules Board Meeting on March 6, 2026 to Consider Q3FY26 Financial ResultsDCMSIL Schedules Board Meeting on March 6, 2026 to Consider Q3FY26 Financial Results
DCMSIL has scheduled a Board of Directors meeting for March 6, 2026, to consider and approve unaudited financial results for the quarter and nine months ended December 31, 2025. This follows the company's recent equity shares listing on February 17, 2026, and complies with SEBI regulations requiring newly listed companies to submit results within 21 days of listing. The company trades on BSE with scrip code 544702 and on NSE with symbol DCMSIL.
*this image is generated using AI for illustrative purposes only.
DCMSIL has announced that its Board of Directors will convene on March 6, 2026, to consider and approve the company's unaudited financial results for the quarter and nine months ended December 31, 2025. The announcement was made through a formal intimation to both BSE Ltd. and the National Stock Exchange of India Ltd. on February 26, 2026.
Regulatory Compliance Following Recent Listing
The board meeting comes as part of the company's regulatory obligations under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Following its equity shares listing on February 17, 2026, DCMSIL is required under Regulation 33(3)(i) to submit its financial results within 21 days from the date of listing.
| Parameter: | Details |
|---|---|
| Meeting Date: | March 6, 2026 |
| Results Period: | Quarter and nine months ended December 31, 2025 |
| Listing Date: | February 17, 2026 |
| Regulatory Deadline: | 21 days from listing date |
| Stock Exchanges: | BSE Ltd. and NSE |
Stock Exchange Details
The company trades on both major Indian stock exchanges with the scrip code 544702 on BSE and symbol DCMSIL on the National Stock Exchange. The formal intimation was signed by Ashish Jha, Company Secretary & Compliance Officer, who holds the professional qualification FCS 11326.
Meeting Agenda and Disclosure
The primary agenda for the March 6, 2026 board meeting centers on reviewing and approving the unaudited financial results. This represents the company's first quarterly results disclosure as a publicly listed entity. The notice regarding this board meeting has been made available on the company's official website at dcmsil.com, ensuring transparency and accessibility for stakeholders.
The timing of this board meeting aligns with the company's commitment to meet regulatory timelines while providing investors with timely financial information following its recent public listing.
15
